BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Alfacell Corporation

Below is an extended Alfacell Corporation patents listing. Click here to return to the Alfacell Corporation main Biocorporate entry.

Alfacell Corporation Patents :

US Patent No.Title
7442536 Cysteinized ribonuclease and targeting moiety conjugated thereto
5529775 Compositions comprising ONCONASE(.TM.) and cisplatin, melphalan, or doxorubicin HCl
5540925 Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (TM)
5559212 Frog embryo and egg-derived tumor cell anti-proliferation protein
5595734 Compositions comprising ONCONASE (tm) and lovastatin
5728805 Pharmaceuticals and method for making them
6175003 Nucleic acids encoding ribonucleases and methods of making them
6239257 Family of proteins belonging to the pancreatic ribonuclease a superfamily
6290951 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
6423515 Methods of making nucleic acids encoding ribonucleases
7229824 Ribonucleases and methods of making them recombinantly
7442535 Fusion protein incorporating a cysteinized ribonuclease
4882421 Pharmaceutical for treating tumors and method for making it

«Alfacell Corporation

This page contained an extended Alfacell Corporation patents listing. Click here to return to the Alfacell Corporation main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.